SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001731122-24-001586
Filing Date
2024-10-10
Accepted
2024-10-10 17:08:24
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A e6019_10-ka.htm 10-K/A 1329937
2 EXHIBIT 23.1 e6019_ex23-1.htm EX-23.1 3580
3 EXHIBIT 31.1 e6019_ex31-1.htm EX-31.1 14286
4 EXHIBIT 31.2 e6019_ex31-2.htm EX-31.2 14190
5 EXHIBIT 32.1 e6019_ex32-1.htm EX-32.1 5957
6 EXHIBIT 32.2 e6019_ex32-2.htm EX-32.2 5861
7 GRAPHIC image_001.jpg GRAPHIC 76477
8 GRAPHIC image_002.jpg GRAPHIC 66285
9 GRAPHIC image_003.jpg GRAPHIC 39245
10 GRAPHIC image_004.jpg GRAPHIC 96760
11 GRAPHIC image_005.jpg GRAPHIC 10527
12 GRAPHIC image_006.jpg GRAPHIC 16077
13 GRAPHIC image_007.jpg GRAPHIC 39958
14 GRAPHIC image_008.jpg GRAPHIC 27754
15 GRAPHIC image_009.jpg GRAPHIC 23689
16 GRAPHIC image_010.jpg GRAPHIC 6802
  Complete submission text file 0001731122-24-001586.txt   1932162
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40064 | Film No.: 241365813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)